首页> 外国专利> A process for the preparation of 1-phenyl- or cyclohexyl-5- (γ-carboxypropyl, γ-hydroxy-n-butyl, β-acetylethyl- or γ-hydroxy-n-butyl) -barbitursyrer or salts thereof.

A process for the preparation of 1-phenyl- or cyclohexyl-5- (γ-carboxypropyl, γ-hydroxy-n-butyl, β-acetylethyl- or γ-hydroxy-n-butyl) -barbitursyrer or salts thereof.

机译:一种制备1-苯基-或环己基-5-(γ-羧丙基,γ-羟基-正丁基,β-乙酰乙基-或γ-羟基-正丁基)-巴比妥尔或其盐的方法。

摘要

1,159,271. Anti-inflammatory &c., medicines. TAKEDA CHEMICAL INDUSTRIES Ltd. 20 July, 1966 [21 July, 1965; 7 May, 1966], No. 32641/66. Heading A5B [Also in Division C2] Pharmaceutical compositions having antiinflammatory and uricosuric activity comprise, as active ingredient, at least one 1,5-disubstituted barbituric acid derivative of the general formula wherein R 1 is a S - hydroxy - n - butyl, - hydroxy - n - butyl or - carboxypropyl group and R 2 is a cyclohexyl or phenyl group, or pharmaceutically acceptable base addition salt thereof, optionally together with aminopyrine or a steroidal anti-inflammatory agent and optionally together with a pharmaceutically acceptable carrier therefor. The compositions may be administered orally, rectally or parenterally.
机译:1,159,271。抗炎药。武田化学工业有限公司1966年7月20日[1965年7月21日;日本。 1966年5月7日],编号32641/66。标题A5B [也在C2部分中]具有抗炎和尿尿尿酸活性的药物组合物包含至少一种通式为R 1为S-羟基-正丁基的R 1,5-二取代的巴比妥酸衍生物作为活性成分。羟基-正丁基或羧基丙基,R 2是环己基或苯基,或其药学上可接受的碱加成盐,任选地与氨基比林或甾体抗炎剂一起,以及任选地与其药学上可接受的载体一起。所述组合物可以口服,直肠或肠胃外给药。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号